MEF2C promoter variants in patent ductus arteriosus: a genetic and functional study
Human Molecular Genetics · 25.09.2026 · 35 (20)
DOI: 10.1093/hmg/ddag097 ↗Kurz gefasst
Fachartikel in der Zeitschrift Human Molecular Genetics, online erschienen am 26.09.2026. Verfasst von Shao-Jie Wang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiovascular Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular Hospital, Tianjin University, No. …. Hauptthemen laut MEDLINE: Ductus Arteriosus, Patent, Promoter Regions, Genetic, MEF2 Transcription Factors. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Internal Fund from TEDA International Cardiovascular Hospital, Tianjin Key Medical Discipline Construction Project.
Abstract (Originalsprache)
Patent ductus arteriosus (PDA) is a common congenital heart disease (CHD) with a complex genetic basis. The transcription factor MEF2C plays a critical role in cardiac development, but the role of promoter region variants in PDA has not been explored. This study aimed to identify MEF2C promoter variants in PDA patients and investigate their functional consequences. We sequenced the MEF2C promoter region in 318 children with PDA and 306 healthy controls. Identified variants were subjected to dual-luciferase reporter assays in A7r5 vascular smooth muscle cells to assess transcriptional activity. Bioinformatics (JASPAR) and electrophoretic mobility shift assays (EMSA) were used to predict and validate changes in transcription factor binding. Seventeen variants were identified, of which seven were present exclusively in PDA patients. Three variants were novel. Dual-luciferase assays showed that six variants significantly altered promoter activity compared to wild-type (range 69.6%–82.3%). JASPAR prediction revealed that these variants affected binding sites for 16 transcription factors, including GATA1, GATA2, GATA3, STAT3, ZEB1 and E2F1. EMSA confirmed altered DNA-protein binding patterns for all six variants, and super-shift assays further validated that the g.24571 A > G variant specifically disrupts GATA3 binding. This is the first study to identify functionally relevant MEF2C promoter variants in PDA. Our findings suggest that dysregulation of MEF2C through promoter variants may contribute to PDA pathogenesis by disrupting critical transcription factor interactions. These results extend the genetic landscape of PDA beyond coding regions and provide new insights into the molecular mechanisms of CHD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiovascular Surgery & The Institute of Cardiovascular Diseases, TEDA International Cardiovascular Hospital, Tianjin University, No. 61, 3rd Ave, TEDA, Tianjin 300457, China.
- Graduate School, Chengde Medical University, Anyuan Road, Shuangqiao District, Chengde 067000, China.
- Tianjin Key Laboratory of Molecular Regulation of Cardiovascular Diseases and Translational Medicine, No. 61, 3rd Ave, TEDA, Tianjin 300457, China.
- TEDA International Cardiovascular Hospital, Chinese Academy of Medical Sciences, No. 61, 3rd Ave, TEDA, Tianjin 300457, China.
ORCID-Profile: Shao-Jie Wang, Huan-Xin Chen, Qin Yang, Guo-Wei He
Förderung
- National Natural Science Foundation of China
- Internal Fund from TEDA International Cardiovascular Hospital
- Tianjin Key Medical Discipline Construction Project
- Special Fund for High Quality Development Project
Zitieren
APA
Wang, S. J., Chen, H. X., Yang, Q., & He, G. W. (2026). MEF2C promoter variants in patent ductus arteriosus: a genetic and functional study. Human Molecular Genetics, 35(20). https://doi.org/10.1093/hmg/ddag097
Vancouver
Wang SJ, Chen HX, Yang Q, He GW. MEF2C promoter variants in patent ductus arteriosus: a genetic and functional study. Human Molecular Genetics. 2026;35(20). doi:10.1093/hmg/ddag097
BibTeX
@article{Wang2026,
author = {Wang, Shao-Jie and Chen, Huan-Xin and Yang, Qin and He, Guo-Wei},
title = {MEF2C promoter variants in patent ductus arteriosus: a genetic and functional study},
journal = {Human Molecular Genetics},
year = {2026},
volume = {35},
number = {20},
doi = {10.1093/hmg/ddag097}
}
EUVIMED